Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Oncogene
|
October 26, 2005
p53 promotes adenoviral replication and increases late viral gene expression
J A Royds, M Hibma, B R Dix, et al.
Journal of Medicinal Chemistry
|
January 6, 2006
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents
Jason A Wiles, Akihiro Hashimoto, Jane A Thanassi, et al.
Surgical Neurology
|
May 1, 1992
Cranioplasty using gentamicin-loaded acrylic cement: a test of neurotoxicity
J F Ronderos, D A Wiles, F A Ragan, et al.
Pharmaceutical Research
|
June 25, 2025
First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Pharmaceutical Research
|
July 14, 2025
Correction: First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Oncogene
|
April 29, 2026
Editorial Expression of Concern: p53 promotes adenoviral replication and increases late viral gene expression
J A Royds, M Hibma, B R Dix, et al.
Plos One
|
July 31, 2012
Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade
Matthew Sharron, Claire E Hoptay, Andrew A Wiles, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
October 14, 2016
International variations in application of the best-interest standard across the age spectrum
N Laventhal, A A E Verhagen, T W R Hansen, et al.
The Journal of Biological Chemistry
|
September 21, 2023
Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediate
Samantha A Crawford, Jason Groegler, Mylinh Dang, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2018
Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activity
Venkat R Gadhachanda, Kyle J Eastman, Qiuping Wang, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Oncogene
|
October 26, 2005
p53 promotes adenoviral replication and increases late viral gene expression
J A Royds, M Hibma, B R Dix, et al.
Journal of Medicinal Chemistry
|
January 6, 2006
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents
Jason A Wiles, Akihiro Hashimoto, Jane A Thanassi, et al.
Surgical Neurology
|
May 1, 1992
Cranioplasty using gentamicin-loaded acrylic cement: a test of neurotoxicity
J F Ronderos, D A Wiles, F A Ragan, et al.
Pharmaceutical Research
|
June 25, 2025
First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Pharmaceutical Research
|
July 14, 2025
Correction: First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases
Venkat R Gadhachanda, Jason A Wiles, Steven D Podos, et al.
Oncogene
|
April 29, 2026
Editorial Expression of Concern: p53 promotes adenoviral replication and increases late viral gene expression
J A Royds, M Hibma, B R Dix, et al.
Plos One
|
July 31, 2012
Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade
Matthew Sharron, Claire E Hoptay, Andrew A Wiles, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
October 14, 2016
International variations in application of the best-interest standard across the age spectrum
N Laventhal, A A E Verhagen, T W R Hansen, et al.
The Journal of Biological Chemistry
|
September 21, 2023
Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediate
Samantha A Crawford, Jason Groegler, Mylinh Dang, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2018
Ferrocene-based inhibitors of hepatitis C virus replication that target NS5A with low picomolar in vitro antiviral activity
Venkat R Gadhachanda, Kyle J Eastman, Qiuping Wang, et al.
Page
of 7